Literature DB >> 15776984

Changes in quality of life for pregnant women in substance user treatment: developing a quality of life index for the addictions.

Marilyn Daley1, Donald S Shepard, Denise Bury-Maynard.   

Abstract

UNLABELLED: Using preference weights from a community sample, items from the Addiction Severity Index (ASI) were converted into a quality of life index (QOLI) and used to compare the cost-effectiveness of five addiction treatment modalities for pregnant women.
METHODS: Interviews using the time trade-off methodology were conducted with 143 members of Massachusetts local health planning boards to determine preference weights for different health states resulting from active addiction. A multi-attribute utility formula was used to convert these seven preference weighted scores into a single QOLI. To apply the QOLI, these preference weights were combined with the number of problem days reported in each ASI domain by a sample of 439 pregnant women in MA in five treatment modalities, 1992-1996.
RESULTS: Starting at 10 years with an addiction problem, board members indicated that they would give up between 0.83 and 3.96 years to avoid the problems in one domain caused by addiction. The average QOLI was 0.68 at intake but increased by 0.19 points by 6-month follow-up to 0.87. All five treatment groups showed notable improvement in their quality of life. Mean improvements ranged from a high of 0.23 QOLIs for clients who received both residential and outpatient treatment to a low of 0.16 for clients who received only detoxification. Treatment costs ranged from 10,187 dollars for residential and outpatient combined to 2535 dollars for detoxification only, with costs per QOLI ranging from 14,912 dollars to 44,291 dollars.
CONCLUSIONS: Although this QOLI could benefit from further refinement and development, it showed promise as a single outcome measure for CEAs in the chemical dependency field. This QOLI was sensitive enough to distinguish between the treatment groups, it correlated well with other outcome measures and can be easily converted from the ASI using spreadsheet software and a simple formula.

Entities:  

Mesh:

Year:  2005        PMID: 15776984     DOI: 10.1081/ja-200030798

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  6 in total

1.  Characteristics and quality of life of opioid-dependent pregnant women in Austria.

Authors:  Verena E Metz; Sandra D Comer; Johanna Wuerzl; Anna Pribasnig; Gabriele Fischer
Journal:  Arch Womens Ment Health       Date:  2014-07-15       Impact factor: 3.633

Review 2.  Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.

Authors:  Jennifer Prah Ruger; Christina M Lazar
Journal:  Addict Behav       Date:  2011-08-05       Impact factor: 3.913

Review 3.  Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions.

Authors:  Mishka Terplan; Shaalini Ramanadhan; Abigail Locke; Nyaradzo Longinaker; Steve Lui
Journal:  Cochrane Database Syst Rev       Date:  2015-04-02

4.  Costs of a motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice for pregnant substance users.

Authors:  Xiao Xu; Kimberly A Yonkers; Jennifer P Ruger
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

5.  Economic evaluation of a behavioral intervention versus brief advice for substance use treatment in pregnant women: results from a randomized controlled trial.

Authors:  Xiao Xu; Kimberly A Yonkers; Jennifer Prah Ruger
Journal:  BMC Pregnancy Childbirth       Date:  2017-03-07       Impact factor: 3.007

6.  Pay-for-performance as a cost-effective implementation strategy: results from a cluster randomized trial.

Authors:  Bryan R Garner; Aung K Lwin; Gail K Strickler; Brooke D Hunter; Donald S Shepard
Journal:  Implement Sci       Date:  2018-07-04       Impact factor: 7.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.